Dr Sarah Elizabeth Rogers, PHARMD, RPH | |
308 Shelburne Rd, Burlington, VT 05401-4919 | |
(802) 864-8154 | |
(802) 660-8774 |
Full Name | Dr Sarah Elizabeth Rogers |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 308 Shelburne Rd, Burlington, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740997634 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 0330134834 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sarah Elizabeth Rogers, PHARMD, RPH 308 Shelburne Rd, Burlington, VT 05401-4919 Ph: (802) 864-8154 | Dr Sarah Elizabeth Rogers, PHARMD, RPH 308 Shelburne Rd, Burlington, VT 05401-4919 Ph: (802) 864-8154 |
News Archive
Humans not only relish the sweet, savory and saltiness of foods, but they are influenced by the environment in which they eat. Cornell University food scientists used virtual reality to show how people's perception of real food can be altered by their surroundings, according to research published in the Journal of Food Science.
This week the U.S. Food and Drug Administration filed complaints initiating the first-ever No-Tobacco-Sale Order (NTSO) actions for a group of retailers who have repeatedly violated certain restrictions on the sale and distribution of tobacco products, including sales to minors. Under the law, the FDA may pursue an NTSO against retailers that have a total of five or more repeated violations of those restrictions during compliance inspections within 36 months.
Among mild to moderately obese patients with type 2 diabetes, adding gastric bypass surgery to lifestyle and medical management was associated with a greater likelihood of improved levels of metabolic risk factors such as blood glucose, LDL-cholesterol and systolic blood pressure, according to a study in the June 5 issue of JAMA.
Researchers at the University of Minnesota have discovered how HIV binds to and destroys a specific human antiviral protein called APOBEC3F. The results suggest that a simple chemical change can convert APOBEC3F to a more effective antiviral agent and that shielding of a common feature shared by related proteins may yield a similar outcome.
Argos Therapeutics today announced that, in an interim analysis of a Phase 2 trial, its Arcelis immunotherapy targeted at HIV, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads.
› Verified 8 days ago
Daeun Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 Farrell St, Burlington, VT 05401 Phone: 802-651-0597 | |
Dr. Kyle Maxwell, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 158 Cherry St, Burlington, VT 05401 Phone: 802-862-1562 | |
Lea Juzek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Shelburne Rd, Burlington, VT 05401 Phone: 802-860-3311 Fax: 802-860-2980 | |
Alan Mccampbell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1127 North Ave Ste 11, Burlington, VT 05408 Phone: 802-862-7752 | |
Hae Ji Yoon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 Shelburne Rd, Burlington, VT 05401 Phone: 802-864-8154 | |
Dr. Sarah Abdalla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 Church St, Burlington, VT 05401 Phone: 803-651-1018 | |
Debra M Gibbs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 S Prospect St, Suite 1413, Burlington, VT 05401 Phone: 802-847-5519 Fax: 802-847-1076 |